Cytokine profiles in patients receiving antioxidant therapy within the ANTICIPATE trial

Table 1 Demographic profiles

Variables	Antioxidant (n = 7)	Placebo (n = 7)	P value
Age (yr), median (range)	46 (34-79)	46 (37-60)	0.92 (Mann-Whitney U)
Gender (male:female)	5:2	4:3	0.90 (Fisher’s exact)
Aetiology	Alcohol 6; idiopathic 1	Alcohol 4; idiopathic 3	0.55 (Fisher’s exact)
Disease duration (yr)	4 (1-5)	3 (2-13)	0.92 (Mann-Whitney U)
Body mass index (kg/m2)	24.2 (18.8-36.7)	22.5 (22.9-32.8)	0.62 (Mann-Whitney U)
Alcohol (g/d), median (range)	175.5 (0-396)	138.6 (0-252)	0.43 (Mann-Whitney U)
Cigarette smoker (Y:N)	6:1	5:2	0.59 (Fisher’s exact)
Diabetes mellitus (Y:N)	2:5	1:6	0.62 (Fisher’s exact)
Faecal elastase (μg/g)	68 (15-500)	27 (15-500)	0.27 (Mann-Whitney U)
Opiate use (mg/d)	40 (30-300)	85 (0-120)	0.30 (Mann-Whitney U)

Laboratory reference range for faecal elastase report values < 200 μg/g as representing end-stage exocrine failure. All opiate intakes are reported as morphine equivalent.